Filing Details
- Accession Number:
- 0001209191-21-036229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-27 16:10:32
- Reporting Period:
- 2021-05-27
- Accepted Time:
- 2021-05-27 16:10:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949858 | Achieve Life Sciences Inc. | ACHV | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1477056 | John Bencich | 22722 29Th Dr Se Suite 100 Bothell WA 98021 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-27 | 6,000 | $7.00 | 6,141 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares reported on this Form 4 were purchased in an underwritten public offering of the Issuer's common stock and are subject to a lock-up agreement between the reporting person and Oppenheimer & Co. Inc., pursuant to which the shares cannot be sold for 90 days following May 25, 2021.
Billionaire Hedge Funds
